Francesco B.
- Country
- Germany
- Department
- Ruhrlandklinik Klinik für Pneumologie
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- Efficacy and Safety of BI 1015550 in Individuals with Interstitial Lung Abnormalities and a Family History of Pulmonary Fibrosis: A Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 251 of 373 partner sites.
Specializations
Pulmonary Fibrosis Research
The investigator specializes in treating various forms of pulmonary fibrosis, with particular focus on idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Their research encompasses innovative therapeutic approaches for managing these chronic lung conditions.
- Fibrotic Lung Disease Management
- Progressive Fibrosing Interstitial Lung Diseases
- Novel Treatment Modalities
Interstitial Lung Disease
The investigator conducts research in interstitial lung diseases, particularly those associated with connective tissue disorders. Their work includes evaluation of advanced therapies for various forms of ILD and their systemic manifestations.
- Connective Tissue Disease-Related ILD
- Sarcoidosis Treatment
- Progressive Fibrosing ILD
Respiratory Symptom Management
The investigator focuses on addressing specific respiratory symptoms, particularly chronic cough in patients with pulmonary fibrosis. Their research extends to alveolar proteinosis and other rare lung conditions requiring specialized therapeutic intervention.
- Chronic Cough Treatment
- Rare Lung Disease Therapy
- Respiratory Function Enhancement
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.